Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
3 hedge funds and large institutions have $1.96M invested in Abeona Therapeutics Inc Warrant in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
23% less capital invested
Capital invested by funds: $2.55M → $1.96M (-$592K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$35 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $1.66M | – | – | – |
|
|
SFM
2
Soros Fund Management
New York
| $300K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | +$35 | +23 | +3% |
|
ABEOW Hedge Fund Activity: Q4 2015 in Review
3 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q4 2015, worth a combined $1.96M — down 23% from $2.55M a quarter earlier.
Fund positioning in ABEOW was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $35.
- 3 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $1.96M of Abeona Therapeutics Inc Warrant stock for Q4 2015, down 23% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q4 2015 and 0 closed out.
- The largest Abeona Therapeutics Inc Warrant buyer in Q4 2015 was UBS Group, an estimated $35 added.
Based on aggregated 13F filings for Q4 2015.